These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1613 related items for PubMed ID: 18610675

  • 1. Efficacy and safety of kanamycin, ethionamide, PAS and cycloserine in multidrug-resistant pulmonary tuberculosis patients.
    Prasad R, Verma SK, Sahai S, Kumar S, Jain A.
    Indian J Chest Dis Allied Sci; 2006; 48(3):183-6. PubMed ID: 18610675
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and safety of sparfloxacin in combination with kanamycin and ethionamide in multidrug-resistant pulmonary tuberculosis patients: preliminary results.
    Singla R, Gupta S, Gupta R, Arora VK.
    Int J Tuberc Lung Dis; 2001 Jun; 5(6):559-63. PubMed ID: 11409584
    [Abstract] [Full Text] [Related]

  • 3. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
    Saito W, Nagayama N, Miyamoto M, Hara H, Suzuki J, Masuda K, Baba M, Tamura A, Nagai H, Akagawa S, Kawabe Y, Machida K, Kurashima A, Yotsumoto H.
    Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
    [Abstract] [Full Text] [Related]

  • 4. [Treatment outcomes of multidrug-resistant tuberculosis--comparison between success and failure cases].
    Shigetoh E, Murakami I, Yokosaki Y, Kurimoto N.
    Kekkaku; 2001 Dec; 76(12):723-8. PubMed ID: 11806128
    [Abstract] [Full Text] [Related]

  • 5. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Park SK, Kim JH, Kang H, Cho JS, Smego RA.
    Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
    [Abstract] [Full Text] [Related]

  • 6. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
    API Consensus Expert Committee.
    J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
    [Abstract] [Full Text] [Related]

  • 7. Susceptibility tests to second line drugs and re-treatment of tuberculosis revisiting early experiences.
    de Kantor IN, Barrera L.
    Medicina (B Aires); 2007 Mar; 67(3):231-7. PubMed ID: 17628909
    [Abstract] [Full Text] [Related]

  • 8. [Effects of two treatment regimens for drug-resistant tuberculosis in tuberculosis control project areas: a comparative study].
    Li L, Zheng SH, Chu NH, Xie YG, Yang YZ, Li Q, Wang XM, Yan XL, Tan WG, Miao ZP, Duanmu HJ.
    Zhonghua Yi Xue Za Zhi; 2008 Dec 30; 88(48):3387-91. PubMed ID: 19159566
    [Abstract] [Full Text] [Related]

  • 9. Tuberculosis chemotherapy and sputum conversion among HIV-seropositive and HIV-seronegative patients in south-eastern Uganda.
    Bwire R, Borgdorff MW, Sticht-Groh V, Rieder HL, Kawuma HJ, Bretzel G, Rüsch-Gerdes S.
    East Afr Med J; 1999 Jun 30; 76(6):307-13. PubMed ID: 10750516
    [Abstract] [Full Text] [Related]

  • 10. [Study on the efficacy and safety of short-term treatment including fluoroquinolones anti-tuberculosis drugs for rifampicin resistant pulmonary tuberculosis].
    Kang WL, Xie YG, Tan WG, Chu NH, Li L, You YH, Yang YZ, Wang XM, Yan XL, Miao ZP, Duanmu HJ.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Feb 30; 30(2):179-83. PubMed ID: 19565883
    [Abstract] [Full Text] [Related]

  • 11. Influence of anti-tuberculosis drug resistance on the treatment outcome of pulmonary tuberculosis patients receiving DOTS in Riyadh, Saudi Arabia.
    Singla R, Al-Sharif N, Al-Sayegh MO, Osman MM, Shaikh MA.
    Int J Tuberc Lung Dis; 2002 Jul 30; 6(7):585-91. PubMed ID: 12102297
    [Abstract] [Full Text] [Related]

  • 12. [The combination of amoxicillin-clavulanic acid and ofloxacin in the treatment of multidrug-resistant Mycobacterium tuberculosis].
    Iwanaga T, Yokota K, Kishikawa R, Ikeda T, Tsurutani H, Hirose T, Nishima S.
    Kekkaku; 1997 Jan 30; 72(1):9-13. PubMed ID: 9038010
    [Abstract] [Full Text] [Related]

  • 13. Revised Category II regimen as an alternative strategy for retreatment of Category I regimen failure and irregular treatment cases.
    Tabarsi P, Chitsaz E, Tabatabaei V, Baghaei P, Shamaei M, Farnia P, Marjani M, Kazempour M, Mansouri D, Masjedi MR, Velayati AA.
    Am J Ther; 2011 Sep 30; 18(5):343-9. PubMed ID: 20535008
    [Abstract] [Full Text] [Related]

  • 14. Radiometric vs. agar proportion methods for assessing ethionamide resistance and its clinical effects in multidrug-resistant tuberculosis.
    Cimen NO, Arslan Z, Saygi A, Ocak K, Babacan F, Kurutepe M.
    Int J Tuberc Lung Dis; 2009 Jul 30; 13(7):907-13. PubMed ID: 19555543
    [Abstract] [Full Text] [Related]

  • 15. [Treatment results of rifampicin (RFP) resistant isoniazid (INH) susceptible tuberculosis, a hospital based study].
    Yoshiyama T, Ogata H, Ito K, Aono A, Wada M.
    Kekkaku; 2007 Feb 30; 82(2):95-101. PubMed ID: 17373318
    [Abstract] [Full Text] [Related]

  • 16. [Two cases of multi-drug-resistant pulmonary tuberculosis with para-aminosalicylic acid (PAS)-induced hypothyroidism].
    Mizutani H, Horiba M, Shindoh J, Kimura T, Son M, Wakahara K.
    Kekkaku; 2001 Oct 30; 76(10):667-72. PubMed ID: 11712388
    [Abstract] [Full Text] [Related]

  • 17. [A case of multi-drug resistant tuberculosis showing psychiatric adverse effect by cycloserine].
    Fujita J, Sunada K, Hayashi H, Hayashihara K, Saito T.
    Kekkaku; 2008 Jan 30; 83(1):21-5. PubMed ID: 18283911
    [Abstract] [Full Text] [Related]

  • 18. Treatment of multiple drug-resistant tuberculosis (MDR-TB) in Iran.
    Mirsaeidi SM, Tabarsi P, Khoshnood K, Pooramiri MV, Rowhani-Rahbar A, Mansoori SD, Masjedi H, Zahirifard S, Mohammadi F, Farnia P, Masjedi MR, Velayati AA.
    Int J Infect Dis; 2005 Nov 30; 9(6):317-22. PubMed ID: 16183321
    [Abstract] [Full Text] [Related]

  • 19. Multidrug-resistant tuberculosis: long-term treatment outcome in the Netherlands.
    Geerligs WA, Van Altena R, De Lange WCM, Van Soolingen D, Van Der Werf TS.
    Int J Tuberc Lung Dis; 2000 Aug 30; 4(8):758-64. PubMed ID: 10949328
    [Abstract] [Full Text] [Related]

  • 20. Clinical characteristics and treatment response among patients with multidrug-resistant tuberculosis: a retrospective study.
    Subhash HS, Ashwin I, Jesudason MV, Abharam OC, John G, Cherian AM, Thomas K.
    Indian J Chest Dis Allied Sci; 2003 Aug 30; 45(2):97-103. PubMed ID: 12715931
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 81.